The Indian neuropsychiatry market is driven by the consumer awareness of health care resulting in access for early treatment along with increasing cases of mental disorders.

Date: 23 December 2015

According to recently published Azoth Analytics report “Indian Neuropsychiatry Drugs Market: Trends, Opportunities and Forecasts (2015-2020F)”, the market has been classified by the drug market and the devices market. Indian neuropsychiatry drugs market is forecast to grow at a CAGR of more than 9.14% during 2015 – 2020F, on account of rising healthcare awareness cases across the globe coupled by increase in Alzheimer’s patients in India. 

Moreover, Medical Tourism is also highly promoted by the government accelerating the growth of the Neuropsychiatry Drugs Market. Neurology has been providing a significant impact on the overall Indian Pharmacy Market. To facilitate un-cooperative patients, oral administrating drugs like Olanzapine have been also introduced. In the neuropsychiatric devices market, the market has been further bifurcated by diagnostic devices type and treatment devices type. The market for devices is valued at USD xx million in 2015 and is estimated to grow by USD xx million in 2020 growing at a CAGR of 9.16% on account of rising cases of brain disorders being diagnosed, where higher number of cases have been witnessed from the urban population, owing to the rising urbanisation and fast paced lifestyle. While patients are recommended the dosage of drugs as treatment, however, when the patient is unresponsive to the drug treatment, further measures of treatment are carried out using the devices such as ECT.  

The report “India Neuropsychiatry (Drugs and Devices) Market: Trends, Opportunities and Forecasts (2015-2020F) - (Segmentation By Value and Volume, By Region, Diagnosis and Treatment Devices, Value Chain, Key Players, Regulatory Perspective, Margins and Revenue Contribution)” has analysed the potential of Indian Neuropsychiatry market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the Indian Neuropsychiatry market. Additionally, the report also highlights market entry strategies for various companies in India along with Product listings of Top Selling drugs as well as manufacturers of devices in the Indian Market (Top 5 Companies).